ReviewJournal of the advanced practitioner in oncology2018
Acute Promyelocytic Leukemia: A Summary.
Review in Journal of the advanced practitioner in oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04562818 (Results From a Mexican Long-term Multicentric Study on Acute Promyelocytic Leukemia.), which is not on this map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Results From a Mexican Long-term Multicentric Study on Acute Promyelocytic Leukemia.
Who cites it
23 citing papers in PubMed.
- Process Development toward DHODH Inhibitor JNJ-6665.ACS organic & inorganic Au · 2026Article
- Article
- Primary Indolent Acute Promyelocytic Leukemia.Hematology reports · 2026Article
- Pro-Apoptotic and Cytotoxic Effects of Melittin on HL-60 Acute Promyelocytic Leukemia Cells: Implications for Retinoid-Independent Therapy.Molecules (Basel, Switzerland) · 2025Article
- Article
- A Rare t(3;15;17) in a Patient with Acute Promyelocytic Leukemia: Case Report and Review of the Literature.Diagnostics (Basel, Switzerland) · 2025Article
- Evaluation of 3D-Printed Microfluidic Structures for Use in AML-Specific Biomarker Detection of PML::RARA.International journal of molecular sciences · 2025Article
- Atypical Chest Pain Leading to the Diagnosis of Acute Promyelocytic Leukemia: A Case Report.Cureus · 2025Article
- Clinico-Pathological Significance and Prognostic Impact of Various PML RARA Transcripts on Outcomes in Acute Promyelocytic Myeloid Leukemia (APML) Treated with Single Agent Arsenic Trioxide(ATO)- Insights from a Tertiary Cancer Center in South India.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2025Article
- A Review of Childhood Acute Myeloid Leukemia: Diagnosis and Novel Treatment.Pharmaceuticals (Basel, Switzerland) · 2023Review
- A Novel Inclusion Body in Acute Promyelocytic LeukemiaTurkish journal of haematology : official journal of Turkish Society of Haematology · 2023Article
- Suchilactone inhibits the growth of acute myeloid leukaemia by inactivating SHP2.Pharmaceutical biology · 2022Article
- Discovery of druggable cancer-specific pathways with application in acute myeloid leukemia.GigaScience · 2022Article
- Article
- Do high-mobility group box 1 gene polymorphisms affect the incidence of differentiation syndrome in acute promyelocytic leukemia?Molecular biology reports · 2022Article
- Cerebral sinus thrombosis as an initial symptom of acute promyelocytic leukemia: Case report and literature review.Surgical neurology international · 2022Article
- Cryptic t(15;17) acute promyelocytic leukemia with a karyotype of add(11)(p15) and t(13,20)- A case report with a literature review.Bosnian journal of basic medical sciences · 2021Review
- Acute Promyelocytic Leukemia: A Long-Term Retrospective Study in Mexico.Journal of hematology · 2021Article
- Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cellsPharmaceutical biology · 2020Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute promyelocytic leukemia is a distinct subtype of acute myeloid leukemia. The disease is characterized by a chromosomal abnormality involving translocation between chromosomes 15 and 17. Current therapy has advanced to include agents such as all-
Identifiers
30588352PMC6303006What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.